Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 73626 - 73650 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	VTCN1	79679	downregulated	Silicon Dioxide analog results in decreased expression of VTCN1 mRNA	1p13.1-p12	A24195
Silicon dioxide	Approved	VTN	7448	downregulated	Silicon Dioxide analog results in decreased expression of VTN mRNA	17q11.2	A24195
Silicon dioxide	Approved	VWA1	64856	downregulated	Silicon Dioxide analog results in decreased expression of VWA1 mRNA	1p36.33	A24195
Silicon dioxide	Approved	VWA5A	4013	upregulated	Silicon Dioxide results in increased expression of VWA5A mRNA	11q24.2	A24196
Silicon dioxide	Approved	WASF3	10810	upregulated	Silicon Dioxide analog results in increased expression of WASF3 mRNA	13q12.13	A24195
Silicon dioxide	Approved	WASF3	10810	downregulated	Silicon Dioxide results in decreased expression of WASF3 mRNA	13q12.13	A24196
Silicon dioxide	Approved	WBP1	23559	downregulated	Silicon Dioxide analog results in decreased expression of WBP1 mRNA	2p13.1	A24195
Silicon dioxide	Approved	WBP2	23558	upregulated	Silicon Dioxide analog results in increased expression of WBP2 mRNA	17q25.1	A24195
Silicon dioxide	Approved	WBSCR28	135886	downregulated	Silicon Dioxide analog results in decreased expression of WBSCR28 mRNA	7q11.23	A24195
Silicon dioxide	Approved	WDFY3	23001	downregulated	Silicon Dioxide analog results in decreased expression of WDFY3 mRNA	4q21.23	A24195
Silicon dioxide	Approved	WDR19	57728	downregulated	Silicon Dioxide results in decreased expression of WDR19 mRNA	4p14	A24196
Silicon dioxide	Approved	WDR3	10885	upregulated	Silicon Dioxide analog results in increased expression of WDR3 mRNA	1p12	A24195
Silicon dioxide	Approved	WDR33	55339	downregulated	Silicon Dioxide analog results in decreased expression of WDR33 mRNA	2q14.3	A24195
Silicon dioxide	Approved	WDR33	55339	upregulated	Silicon Dioxide results in increased expression of WDR33 mRNA	2q14.3	A24196
Silicon dioxide	Approved	WDR43	23160	upregulated	Silicon Dioxide analog results in increased expression of WDR43 mRNA	2p23.2	A24195
Silicon dioxide	Approved	WDR5B	54554	downregulated	Silicon Dioxide results in decreased expression of WDR5B mRNA	3q21.1	A24196
Silicon dioxide	Approved	WDR60	55112	downregulated	Silicon Dioxide analog results in decreased expression of WDR60 mRNA	7q36.3	A24195
Silicon dioxide	Approved	WDR62	284403	upregulated	Silicon Dioxide analog results in increased expression of WDR62 mRNA	19q13.12	A24195
Silicon dioxide	Approved	WDR63	126820	downregulated	Silicon Dioxide analog results in decreased expression of WDR63 mRNA	1p22.3	A24195
Silicon dioxide	Approved	WDR66	144406	upregulated	Silicon Dioxide analog results in increased expression of WDR66 mRNA	12q24.31	A24195
Silicon dioxide	Approved	WDR73	84942	upregulated	Silicon Dioxide analog results in increased expression of WDR73 mRNA	15q25.2	A24195
Silicon dioxide	Approved	WDR74	54663	upregulated	Silicon Dioxide analog results in increased expression of WDR74 mRNA	11q12.3	A24195
Silicon dioxide	Approved	WDR77	79084	downregulated	Silicon Dioxide results in decreased expression of WDR77 mRNA	1p13.2	A24196
Silicon dioxide	Approved	WDR90	197335	upregulated	Silicon Dioxide analog results in increased expression of WDR90 mRNA	16p13.3	A24195
Silicon dioxide	Approved	WFDC2	10406	downregulated	Silicon Dioxide analog results in decreased expression of WFDC2 mRNA	20q13.12	A24195

Displaying entries 73626 - 73650 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability